Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort

Autor: John Londono, Cesar Pacheco-Tena, Ana Maria Santos, Mario Humberto Cardiel, Gustavo Rodríguez-Salas, Igor Rueda, Sofía Arias-Correal, Cristian Mesa, Mantilla Marta Juliana, Juan Camilo Santacruz, Juan Camilo Rueda, Gilberto Vargas-Alarcón, Rubén Burgos-Vargas

Publikováno v: Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)

Abstract To compare the demographic, clinical, and laboratory characteristics, disease onset, and clinical features of radiographic axial Spondyloarthritis (r-axSpA) and non-radiographic axial Spondyloarthritis (nr-axSpA) patients. All patients who a

Externí odkaz: https://doaj.org/article/76b4652d4d1d4b78a0f7e9786d196f39

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

Autor: Josef S Smolen, Robert B M Landewé, Johannes W J Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B McInnes, Alexandre Sepriano, Ronald F van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, John Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Mario Humberto Cardiel, Diederik De Cock, Catalin Codreanu, Maurizio Cutolo, Christopher John Edwards, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques-Eric Gottenberg, Merete Lund Hetland, Tom W J Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller-Ladner, Eduardo F Mysler, Jose A P da Silva, Gyula Poór, Janet E Pope, Andrea Rubbert-Roth, Adeline Ruyssen-Witrand, Kenneth G Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde

Publikováno v: Annals of the Rheumatic Diseases, 79, 6, pp. 685-699
Smolen, J S, Landewé, R B M, Bijlsma, J W J, Burmester, G R, Dougados, M, Kerschbaumer, A, McInnes, I B, Sepriano, A, Van Vollenhoven, R F, De Wit, M, Aletaha, D, Aringer, M, Askling, J, Balsa, A, Boers, M, Den Broeder, A A, Buch, M H, Buttgereit, F, Caporali, R, Cardiel, M H, De Cock, D, Codreanu, C, Cutolo, M, Edwards, C J, Van Eijk-Hustings, Y, Emery, P, Finckh, A, Gossec, L, Gottenberg, J E, Hetland, M L, Huizinga, T W J, Koloumas, M, Li, Z, Mariette, X, Müller-Ladner, U, Mysler, E F, Da Silva, J A P, Poór, G, Pope, J E, Rubbert-Roth, A, Ruyssen-Witrand, A, Saag, K G, Strangfeld, A, Takeuchi, T, Voshaar, M, Westhovens, R & Van Der Heijde, D 2020, ' EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs : 2019 update ', Annals of the Rheumatic Diseases, vol. 79, no. 6, pp. S685-S699 . https://doi.org/10.1136/annrheumdis-2019-216655
Annals of the Rheumatic Diseases, 79(6), S685-S699. BMJ Publishing Group
Annals of the rheumatic diseases, 79(6), S685-S699. BMJ
Annals of the rheumatic diseases, 79(6), S685-S699. BMJ Publishing Group
Annals of the Rheumatic Diseases, 79, 685-699
Annals of the Rheumatic Diseases, Vol. 79, No 6 (2020) pp. 685-699

ObjectivesTo provide an update of the European League Against Rheumatism (EULAR) rheumatoid arthritis (RA) management recommendations to account for the most recent developments in the field.MethodsAn international task force considered new evidence

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce57ec94436536e6b1645c3a6fc84b6
https://doi.org/10.1136/annrheumdis-2019-216655

Syndemic and syndemogenesis of low back pain in Latin-American population: a network and cluster analysis

Autor: Alfonso Gastelum, Strozzi, Ingris, Peláez-Ballestas, Ysabel, Granados, Rubén, Burgos-Vargas, Rosana, Quintana, John, Londoño, Sergio, Guevara, Oscar, Vega-Hinojosa, José, Alvarez-Nemegyei, Vicente, Juarez, César, Pacheco-Tena, Ligia, Cedeño, Mario, Garza-Elizondo, Ana María, Santos, María Victoria, Goycochea-Robles, Astrid, Feicán, Hazel, García, Flor, Julian-Santiago, María Elena, Crespo, Jacqueline, Rodriguez-Amado, Juan Camilo, Rueda, Adriana, Silvestre, Jorge, Esquivel-Valerio, Celenia, Rosillo, Susana, Gonzalez-Chavez, Everardo, Alvarez-Hernández, Adalberto, Loyola-Sanchez, Eduardo, Navarro-Zarza, Marco, Maradiaga, Julio, Casasola-Vargas, Natalia, Sanatana, Imelda, Garcia-Olivera, Mario, Goñi, Luz Helena, Sanin, Rocío, Gamboa, Mario Humberto, Cardiel, Bernardo A, Pons-Estel

Publikováno v: Clinical rheumatology. 39(9)

Although low back pain (LBP) is a high-impact health condition, its burden has not been examined from the syndemic perspective.To compare and assess clinical, socioeconomic, and geographic factors associated with LBP prevalence in low-income and uppe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a46cf05f1ac9b54504cbbbc0d81a2625
https://pubmed.ncbi.nlm.nih.gov/32232735

Mielitis transversa en síndrome de Sjögren y lupus eritematoso sistémico: presentación de 3 casos

Autor: Carmen García Guijo, Raúl Menor Almagro, Juan Girón Úbeda, Mario Humberto Cardiel Ríos, María del Mar Ruiz Tudela, José Javier Pérez Venegas

Publikováno v: Reumatología Clínica. 11:41-44

Resumen La mielitis transversa es una inflamacion focal poco frecuente de la medula espinal. Su etiologia es multiple y entre ellas se encuentran las enfermedades autoinmunes, incluyendo principalmente el lupus eritematoso sistemico y el sindrome de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3d749d4f9fe0dff58390b4841f514072
https://doi.org/10.1016/j.reuma.2014.03.008

Medicamentos biocomparables en México: la postura del Colegio Mexicano de Reumatología, 2012

Autor: Eduardo Rubén Barreira Mercado, Juan Osvaldo Talavera Piña, Leonor Adriana Barile Fabris, Francisco Javier Flores Murrieta, Antonio Fraga Mouret, Jorge Antonio Esquivel Valerio, César Alejandro Arce Salinas, Miguel Luján Estrada, Alejandro Díaz Borjón, Mario Alberto Garza Elizondo, Rolando Espinosa Morales, Olga Lidia Vera Lastra, Efraín Díaz Jouanen, Francisco José Muñoz Barradas, Gabriel Medrano Ramírez, Mario Humberto Cardiel Ríos

Publikováno v: Reumatología Clínica. 9:113-116

a b s t r a c t Biotechnological drugs (BTDs) are complex molecules whose manufacturing process precludes the ability to identically reproduce the structure of the original product, and therefore there cannot be an absolute

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f987e74babd2069f413d48866be163c2
https://doi.org/10.1016/j.reuma.2012.11.001